ArticleHeliyon2026
Expression of concern: "Evaluating the therapeutic effects of isotretinoin on patients with coronavirus disease 2019 (COVID-19): A controlled open-label clinical trial" [Heliyon 10 (2024) e26685].
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.